See also this year's filing and all EDGAR filings for this company.
PDF Report 0001481512_2018_Ra_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001481512, Ra Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 72,877,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 380,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,606,000 |
| 3 | remainder_Assets | 1,334,000 |
| 4 | LiabilitiesCurrent | 8,614,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,399,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,778,000 |
| 9 | ResearchAndDevelopmentExpense | 45,251,000 |
| 10 | remainder_Expenses | -19,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 571,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 80,197,000 |
| 1 | Liabilities | 11,013,000 |
| 2 | Expenses | 55,010,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 69,184,000 |
| 5 | NetIncome | -54,439,000 |
| 6 | ComprehensiveNetIncome | -54,439,000 |
| 7 | BaseVar | 73,395,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.11 |
| 9 | EconomicCapitalRatio | 3.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
